Not only are tumours are different from one another, but there can even be genetic differences within a single tumour.
A new chemotherapy regime has proved to shrink tumours twice as fast as in normal methods in patients with aggressive breast cancer carrying a faulty BRCA gene, according to a clinical trial.
Color Genomics unveils its plan to give people a peek into their genetic risk, by offering a test for hereditary cancer and high cholesterol. But, they are offering more than just that.
Much of medicine is about information — the data that helps doctors make the right choices about our treatment. So how will the revolution in big data impact complex healthcare systems like the NHS?
Geisinger Health System CEO, Dr. David Feinberg reveals health system’s pioneering precision health efforts will be recommended to every patient.
A new cell-based medicine is offering hope for children suffering from incurable nerve tissue cancer, posing a dilemma for investors.
There is concern that the White House is considering imposing further limits on research by Chinese citizens in the United States, saying that “scientific progress depends on openness, transparency, and the free flow of ideas”
The link between cancer mutations and DNA repair mechanisms has been well established. However, the specific origins of the mutation in these essential pathways have remained enigmatic. Now, researchers have used human and worm data to explore the mutational causes of cancer.
Harvard scientist, George Church is putting his efforts into using an alternative, older technology in a bid to recode an entire human genome in hundreds of thousands of locations in order to make it immune to viruses.
The National Insitute of Health is finally launching All of Us, a huge research study with the aim of making precision medicine available to people of all backgrounds. But will people give up their data?
Deep learning computers in a diagnostic imaging lab routinely defeat their human counterparts in diagnosing heart failure, detecting various cancers and predicting their strength.
A new method for diagnosing breast cancer involves a pill, which could do a better job distinguishing between benign and aggressive tumours.
We have achieved so much since the full human genome sequence was published for the first time, can you believe that was over fifteen years ago this month?
Researchers have mapped the genetic variants that increase the risk of depression, in a bid to understand why depression strikes some people and not others.